PDT Partners’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-28,895
| Closed | -$74.8K | – | 699 |
|
|
2023
Q2 | $74.8K | Sell |
28,895
-45,823
| -61% | -$119K | 0.01% | 541 |
|
|
2023
Q1 | $305K | Sell |
74,718
-29,665
| -28% | -$121K | 0.04% | 458 |
|
|
2022
Q4 | $524K | Buy |
104,383
+70,116
| +205% | +$352K | 0.08% | 375 |
|
|
2022
Q3 | $448K | Buy |
+34,267
| New | +$448K | 0.07% | 465 |
|
|
2022
Q2 | – | Sell |
-38,179
| Closed | -$582K | – | 1199 |
|
|
2022
Q1 | $582K | Sell |
38,179
-19,367
| -34% | -$295K | 0.05% | 532 |
|
|
2021
Q4 | $1.02M | Buy |
57,546
+3,300
| +6% | +$58.4K | 0.08% | 356 |
|
|
2021
Q3 | $1.14M | Buy |
54,246
+18,046
| +50% | +$379K | 0.08% | 319 |
|
|
2021
Q2 | $714K | Buy |
+36,200
| New | +$714K | 0.05% | 439 |
|
|
2020
Q2 | – | Sell |
-13,150
| Closed | -$162K | – | 855 |
|
|
2020
Q1 | $162K | Buy |
+13,150
| New | +$162K | 0.01% | 582 |
|